At Belay Diagnostics, our mission is to serve patients and those who care for them
An innovative and dynamic approach to evaluating suspected brain tumors
High-performance liquid biopsy assay to help detect primary and secondary CNS malignancies
Genomic profiling is critical for staging, improving treatment decisions, and monitoring. However, cytology is inadequate and biopsies are invasive and risky. Our high-performance cerebrospinal fluid assay is designed to offer an innovative alternative.
Your partner in a higher standard of care
Summit™, a novel liquid biopsy test clinically validated in cerebrospinal fluid, offers clinicians an advanced method to help inform diagnosis and treatment decisions for patients with central nervous system malignancies that may preempt biopsy in certain instances.
High-performance liquid biopsy assay to help detect primary and secondary CNS malignancies
Genomic profiling is critical for staging, improving treatment decisions, and monitoring. However, cytology is inadequate and biopsies are invasive and risky. Our high-performance cerebrospinal fluid assay is designed to offer an innovative alternative.
Your partner in a higher standard of care
Summit™, a novel liquid biopsy test clinically validated in cerebrospinal fluid, offers clinicians an advanced method to help inform diagnosis and treatment decisions for patients with central nervous system malignancies that may preempt biopsy in certain instances.